An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.
Some professionals said the demand for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer laws, risking penalties, legal action or prison.
Service Reaction and Material Removal
Based on TikTok, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.
After minutes of entering one group, a vendor shared contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Details and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly significant medical dangers”.
